Additionally, reduction in NF-κB signaling in a COPD-PH mouse model (intratracheal-elastase-induced emphysema) through budesonide/glycopyrronium/formoterol fumarate triple therapy prevented PH development and decreased COPD progression [86]. Here, NFKB1 is linked to chronic obstructive pulmonary disease.